{"title":"GABAB受體腦炎患者的康復軌跡個案報告","authors":"廖晏輝 廖晏輝, 陳冠宇 陳冠宇, 姜振華 Guan-Yu Chen, 李耀東 李耀東, 黃立楷 黃立楷","doi":"10.53106/181020932023122104004","DOIUrl":null,"url":null,"abstract":"自體免疫性抗GABAB受體腦炎是一種罕見的疾病,在最初的神經精神症狀發生後,也常伴隨後遺症。我們提出一例經腦脊液檢測證實的抗GABAB受體腦炎病例,並由磁振造影成像 (MRI) 檢測到相應的左顳葉病變。透過長時間追蹤與臨床觀察、多次腦部磁振造影成像和認知功能,持續記錄其康復軌跡,提出縱貫性證據,並且在此個案中,使用重複大劑量皮質類固醇衝擊療法,有效地阻止了患者的疾病惡化並具有良好的反應性。 Autoimmune anti-GABAB receptor encephalitis is a rare form of limbic en-cephalitis that typically has an initial neuropsychiatric presentation followed by se-qualae. Here, we present a case of anti-GABAB receptor encephalitis confirmed by cerebrospinal fluid testing and a corresponding left temporal lobe lesion detected by brain magnetic resonance imaging (MRI). Longitudinal evidence from clinical ob-servation, brain MRIs, and the ascending trajectory of his cognitive performance confirmed that the repeated high-dose corticosteroid pulse therapy effectively halted the patient’s disease progression with favorable responsiveness.","PeriodicalId":188376,"journal":{"name":"輔仁醫學期刊","volume":"91 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GABAB受體腦炎患者的康復軌跡個案報告\",\"authors\":\"廖晏輝 廖晏輝, 陳冠宇 陳冠宇, 姜振華 Guan-Yu Chen, 李耀東 李耀東, 黃立楷 黃立楷\",\"doi\":\"10.53106/181020932023122104004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"自體免疫性抗GABAB受體腦炎是一種罕見的疾病,在最初的神經精神症狀發生後,也常伴隨後遺症。我們提出一例經腦脊液檢測證實的抗GABAB受體腦炎病例,並由磁振造影成像 (MRI) 檢測到相應的左顳葉病變。透過長時間追蹤與臨床觀察、多次腦部磁振造影成像和認知功能,持續記錄其康復軌跡,提出縱貫性證據,並且在此個案中,使用重複大劑量皮質類固醇衝擊療法,有效地阻止了患者的疾病惡化並具有良好的反應性。 Autoimmune anti-GABAB receptor encephalitis is a rare form of limbic en-cephalitis that typically has an initial neuropsychiatric presentation followed by se-qualae. Here, we present a case of anti-GABAB receptor encephalitis confirmed by cerebrospinal fluid testing and a corresponding left temporal lobe lesion detected by brain magnetic resonance imaging (MRI). Longitudinal evidence from clinical ob-servation, brain MRIs, and the ascending trajectory of his cognitive performance confirmed that the repeated high-dose corticosteroid pulse therapy effectively halted the patient’s disease progression with favorable responsiveness.\",\"PeriodicalId\":188376,\"journal\":{\"name\":\"輔仁醫學期刊\",\"volume\":\"91 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"輔仁醫學期刊\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53106/181020932023122104004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"輔仁醫學期刊","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53106/181020932023122104004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
自體免疫性抗GABAB受體腦炎是一種罕見的疾病,在最初的神經精神症狀發生後,也常伴隨後遺症。我們提出一例經腦脊液檢測證實的抗GABAB受體腦炎病例,並由磁振造影成像 (MRI) 檢測到相應的左顳葉病變。透過長時間追蹤與臨床觀察、多次腦部磁振造影成像和認知功能,持續記錄其康復軌跡,提出縱貫性證據,並且在此個案中,使用重複大劑量皮質類固醇衝擊療法,有效地阻止了患者的疾病惡化並具有良好的反應性。 Autoimmune anti-GABAB receptor encephalitis is a rare form of limbic en-cephalitis that typically has an initial neuropsychiatric presentation followed by se-qualae. Here, we present a case of anti-GABAB receptor encephalitis confirmed by cerebrospinal fluid testing and a corresponding left temporal lobe lesion detected by brain magnetic resonance imaging (MRI). Longitudinal evidence from clinical ob-servation, brain MRIs, and the ascending trajectory of his cognitive performance confirmed that the repeated high-dose corticosteroid pulse therapy effectively halted the patient’s disease progression with favorable responsiveness.